Clinical trial
Magnetic Resonance Imaging to Evaluate Prostate Cancer
NCT00182624 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00182624 |
|---|---|
| Title | Magnetic Resonance Imaging to Evaluate Prostate Cancer |
| Official title | Comprehensive Prostate MRI for the Evaluation of Prostate Cancer at 3.0T: A Pilot Study |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Prostatic Neoplasms |
| Enrollment | 80 |
| Start date | Feb 2, 2004 |
| Completion | Sep 6, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: